Zhu, Hai-Dong
Li, Xiao
Sun, Jun-Hui
Zhu, Xu
Liu, Zhao-Yu
Li, Hai-Liang
Lu, Jian
Yan, Zhi-Ping
Shao, Guo-Liang
He, Xiao-Feng
Chao, Min
Lu, Li-Gong
Zhong, Bin-Yan
Li, Rui
Zhang, Qi
Teng, Gao-Jun http://orcid.org/0000-0003-1145-0798
Clinical trials referenced in this document:
Documents that mention this clinical trial
Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial)
https://doi.org/10.1007/s00270-024-03666-4
Article History
Received: 24 June 2023
Accepted: 16 January 2024
First Online: 27 February 2024
Declarations
:
: The authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All authors have reviewed this manuscript and support its submission. Consent for publication was obtained for every individual person’s data included in the study.
: Informed consent was obtained from all individual participants included in the study.